Retrophin Inc at Barclays Global Healthcare Conference Transcript
Thank you, everyone. My name is Gena Wang. I'm SMID-cap biotech analyst at the Barclays. I first hope everyone stay healthy, and I would like to thank all the participants, investors, companies, especially our event team and corporate access team, who made this virtual health care conference possible.
With that, I would like to introduce our next speakers from Retrophin. We have Eric Dube, Chief Executive Officer; we also have Chris Cline, SVP of Investor Relations.
Eric, I will hand over to you.
Okay. Thank you, Gena, and thank you, Barclays, for the opportunity to present some updates on our company.
Let me go to Slide 2. Today, I will be speaking to a number of forward-looking statements, and you can see our disclosures here, online and in our SEC filings.
If you move to Slide 3, I'd like to give a brief overview of our company. At Retrophin, we are completely dedicated to developing and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investorsā 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
